0.040634 0.000000 0.000000 0.000000 0.021891 0.000000 0.000000 0.000000 0.015699 0.00000 0.00000 0.00000 Mochalkin, I. Tulinsky, A. Scanu, A. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 4 90.00 90.00 90.00 24.610 45.680 63.700 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 38 1990 1998 10.1021/bi9820558 10026282 Recombinant kringle IV-10 modules of human apolipoprotein(a): structure, ligand binding modes, and biological relevance. 1999 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 130 1 MSC-YALE MIRRORS IMAGE PLATE 1997-10 RIGAKU RAXIS II NI FILTER M x-ray 1 1.5418 1.0 1.5418 ROTATING ANODE RIGAKU RUH2R KIV-10/M66 VARIANT OF HUMAN APOLIPOPROTEIN(A) 9070.976 APOLIPOPROTEIN A KRINGLE IV-10 1 man polymer 18.015 water 67 nat water no no CYHGNGQSYRGTFSTTVTGRTCQSWSSMTPHRHQRTPENYPNDGLTMNYCRNPDADTGPWCFTMDPSIRWEYCNLTRC CYHGNGQSYRGTFSTTVTGRTCQSWSSMTPHRHQRTPENYPNDGLTMNYCRNPDADTGPWCFTMDPSIRWEYCNLTRC A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample 9606 Homo sapiens 562 Escherichia coli 1 1.76 30.6 7.0 pH 7.0 repository Initial release Version format compliance Version format compliance 1 0 1999-05-18 1 1 2008-03-24 1 2 2011-07-13 Y 1998-08-26 REL HOH water N-TERMINAL (VRQ) AND C-TERMINAL (SDTEGTV) INTERKRINGULAR PARTS ARE DISORDERED. THE P30 RESIDUE IS IN CIS CONFORMATION. M66T POLYMORPHISM IS BIOLOGICALLY SILENT. HOH 200 2 HOH HOH 200 A HOH 201 2 HOH HOH 201 A HOH 202 2 HOH HOH 202 A HOH 203 2 HOH HOH 203 A HOH 204 2 HOH HOH 204 A HOH 205 2 HOH HOH 205 A HOH 206 2 HOH HOH 206 A HOH 207 2 HOH HOH 207 A HOH 208 2 HOH HOH 208 A HOH 209 2 HOH HOH 209 A HOH 210 2 HOH HOH 210 A HOH 211 2 HOH HOH 211 A HOH 212 2 HOH HOH 212 A HOH 213 2 HOH HOH 213 A HOH 214 2 HOH HOH 214 A HOH 215 2 HOH HOH 215 A HOH 216 2 HOH HOH 216 A HOH 217 2 HOH HOH 217 A HOH 218 2 HOH HOH 218 A HOH 219 2 HOH HOH 219 A HOH 220 2 HOH HOH 220 A HOH 221 2 HOH HOH 221 A HOH 222 2 HOH HOH 222 A HOH 223 2 HOH HOH 223 A HOH 224 2 HOH HOH 224 A HOH 225 2 HOH HOH 225 A HOH 226 2 HOH HOH 226 A HOH 227 2 HOH HOH 227 A HOH 228 2 HOH HOH 228 A HOH 229 2 HOH HOH 229 A HOH 230 2 HOH HOH 230 A HOH 231 2 HOH HOH 231 A HOH 232 2 HOH HOH 232 A HOH 233 2 HOH HOH 233 A HOH 234 2 HOH HOH 234 A HOH 235 2 HOH HOH 235 A HOH 236 2 HOH HOH 236 A HOH 237 2 HOH HOH 237 A HOH 238 2 HOH HOH 238 A HOH 239 2 HOH HOH 239 A HOH 240 2 HOH HOH 240 A HOH 241 2 HOH HOH 241 A HOH 242 2 HOH HOH 242 A HOH 243 2 HOH HOH 243 A HOH 244 2 HOH HOH 244 A HOH 245 2 HOH HOH 245 A HOH 246 2 HOH HOH 246 A HOH 247 2 HOH HOH 247 A HOH 248 2 HOH HOH 248 A HOH 249 2 HOH HOH 249 A HOH 250 2 HOH HOH 250 A HOH 251 2 HOH HOH 251 A HOH 252 2 HOH HOH 252 A HOH 253 2 HOH HOH 253 A HOH 254 2 HOH HOH 254 A HOH 255 2 HOH HOH 255 A HOH 256 2 HOH HOH 256 A HOH 257 2 HOH HOH 257 A HOH 258 2 HOH HOH 258 A HOH 259 2 HOH HOH 259 A HOH 260 2 HOH HOH 260 A HOH 261 2 HOH HOH 261 A HOH 262 2 HOH HOH 262 A HOH 263 2 HOH HOH 263 A HOH 264 2 HOH HOH 264 A HOH 265 2 HOH HOH 265 A HOH 266 2 HOH HOH 266 A CYS 1 n 1 CYS 1 A TYR 2 n 2 TYR 2 A HIS 3 n 3 HIS 3 A GLY 4 n 4 GLY 4 A ASN 5 n 5 ASN 5 A GLY 6 n 6 GLY 6 A GLN 7 n 7 GLN 7 A SER 8 n 8 SER 8 A TYR 9 n 9 TYR 9 A ARG 10 n 10 ARG 10 A GLY 11 n 11 GLY 11 A THR 12 n 12 THR 12 A PHE 13 n 13 PHE 13 A SER 14 n 14 SER 14 A THR 15 n 15 THR 15 A THR 16 n 16 THR 16 A VAL 17 n 17 VAL 17 A THR 18 n 18 THR 18 A GLY 19 n 19 GLY 19 A ARG 20 n 20 ARG 20 A THR 21 n 21 THR 21 A CYS 22 n 22 CYS 22 A GLN 23 n 23 GLN 23 A SER 24 n 24 SER 24 A TRP 25 n 25 TRP 25 A SER 26 n 26 SER 26 A SER 27 n 27 SER 27 A MET 28 n 28 MET 28 A THR 29 n 29 THR 29 A PRO 30 n 30 PRO 30 A HIS 31 n 31 HIS 31 A ARG 32 n 32 ARG 32 A HIS 33 n 33 HIS 33 A GLN 34 n 34 GLN 34 A ARG 35 n 35 ARG 35 A THR 37 n 36 THR 37 A PRO 38 n 37 PRO 38 A GLU 39 n 38 GLU 39 A ASN 40 n 39 ASN 40 A TYR 41 n 40 TYR 41 A PRO 42 n 41 PRO 42 A ASN 43 n 42 ASN 43 A ASP 44 n 43 ASP 44 A GLY 45 n 44 GLY 45 A LEU 46 n 45 LEU 46 A THR 47 n 46 THR 47 A MET 48 n 47 MET 48 A ASN 49 n 48 ASN 49 A TYR 50 n 49 TYR 50 A CYS 51 n 50 CYS 51 A ARG 52 n 51 ARG 52 A ASN 53 n 52 ASN 53 A PRO 54 n 53 PRO 54 A ASP 55 n 54 ASP 55 A ALA 56 n 55 ALA 56 A ASP 57 n 56 ASP 57 A THR 58 n 57 THR 58 A GLY 60 n 58 GLY 60 A PRO 61 n 59 PRO 61 A TRP 62 n 60 TRP 62 A CYS 63 n 61 CYS 63 A PHE 64 n 62 PHE 64 A THR 65 n 63 THR 65 A MET 66 n 64 MET 66 A ASP 67 n 65 ASP 67 A PRO 68 n 66 PRO 68 A SER 69 n 67 SER 69 A ILE 70 n 68 ILE 70 A ARG 71 n 69 ARG 71 A TRP 72 n 70 TRP 72 A GLU 73 n 71 GLU 73 A TYR 74 n 72 TYR 74 A CYS 75 n 73 CYS 75 A ASN 76 n 74 ASN 76 A LEU 77 n 75 LEU 77 A THR 78 n 76 THR 78 A ARG 79 n 77 ARG 79 A CYS 80 n 78 CYS 80 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O CYS 63 A O CYS 61 A N GLU 73 A N GLU 71 1 A A CG2 NH2 THR ARG 18 20 2.06 1 A A OG1 OE2 THR GLU 16 73 2.11 1 A A CB O CYS THR 1 78 2.14 1 A ARG 20 0.138 SIDE CHAIN 1 4.67 0.50 120.30 124.97 A A A NE CZ NH1 ARG ARG ARG 10 10 10 N 1 -3.78 0.50 120.30 116.52 A A A NE CZ NH2 ARG ARG ARG 10 10 10 N 1 11.55 1.90 111.40 122.95 A A A CB CA C VAL VAL VAL 17 17 17 N 1 3.37 0.50 120.30 123.67 A A A NE CZ NH1 ARG ARG ARG 20 20 20 N 1 -3.86 0.50 120.30 116.44 A A A NE CZ NH2 ARG ARG ARG 20 20 20 N 1 4.51 0.50 120.30 124.81 A A A NE CZ NH1 ARG ARG ARG 32 32 32 N 1 12.68 1.40 123.60 136.28 A A A CD NE CZ ARG ARG ARG 52 52 52 N 1 7.58 0.50 120.30 127.88 A A A NE CZ NH1 ARG ARG ARG 52 52 52 N 1 -3.74 0.50 120.30 116.56 A A A NE CZ NH2 ARG ARG ARG 52 52 52 N 1 -5.98 0.90 118.30 112.32 A A A CB CG OD2 ASP ASP ASP 67 67 67 N 1 5.10 0.50 120.30 125.40 A A A NE CZ NH1 ARG ARG ARG 71 71 71 N 1 -4.17 0.50 120.30 116.13 A A A NE CZ NH2 ARG ARG ARG 71 71 71 N 1 13.54 2.20 113.40 126.94 A A A CA CB CG GLU GLU GLU 73 73 73 N 1 A LEU 46 -55.58 41.71 1 A MET 48 41.73 -129.18 1 A TYR 50 -46.24 154.29 1 A ASP 57 -75.75 -169.84 1 A TRP 62 -126.16 -158.31 1 A CYS 63 176.42 161.22 1 A ARG 79 -60.04 86.26 21.8 0.178 2.1 9.0 3144 67 1 1.0 MOLECULAR REPLACEMENT 2.1 9.0 67 701 0 0 634 0.012 0.020 0.032 0.040 0.043 0.050 1.151 1.500 1.814 2.000 2.103 2.500 2.954 3.000 0.024 0.030 0.125 0.130 0.18 0.60 0.26 0.60 0.32 0.60 3.7 3.0 20.6 15.0 25.2 20.0 2.1 23.0 1KIV 3822 0.062 1 10.7 2.5 81 0.15 2.1 2.25 3.0 64 data collection RIGAKU R-AXIS data reduction RIGAKU R-AXIS refinement PROFFT data reduction R-AXIS (RIGAKU) data scaling R-AXIS (RIGAKU) APOLIPOPROTEIN A RECOMBINANT KRINGLE IV-10/M66 VARIANT OF HUMAN APOLIPOPROTEIN(A) 1 N N 2 N N disulf 2.078 A CYS 1 A SG CYS 1 1_555 A CYS 80 A SG CYS 78 1_555 disulf 2.003 A CYS 22 A SG CYS 22 1_555 A CYS 63 A SG CYS 61 1_555 disulf 2.042 A CYS 51 A SG CYS 50 1_555 A CYS 75 A SG CYS 73 1_555 KRINGLE KRINGLE, LYSINE BINDING SITE, APOLIPOPROTEIN(A) A THR 29 A THR 29 1 A PRO 30 A PRO 30 -2.16 APOA_HUMAN UNP 1 1 P08519 MEHKEVVLLLLLFLKSAAPEQSHVVQDCYHGDGQSYRGTYSTTVTGRTCQAWSSMTPHQHNRTTENYPNAGLIMNYCRNP DAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTG RTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEA PSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRD PGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPH SHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPG VQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQ CSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNA GLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSY RGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPP TVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDA VAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRT CQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPS EQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPG VRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSH SRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQ ECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCS DAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGL IMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRG TYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTV TPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVA APYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQ AWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQ APTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVR WEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSR TPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQEC YHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDA EGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIM NYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTY STTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTP VPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAP YCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAW SSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAP TEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWE YCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTP EYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYH GNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEG TAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNY CRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYST TVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVP SLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYC YTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSS MTPHSHSRTPEYYPNAGLIMNYCRNPDPVAAPYCYTRDPSVRWEYCNLTQCSDAEGTAVAPPTITPIPSLEAPSEQAPTE QRPGVQECYHGNGQSYQGTYFITVTGRTCQAWSSMTPHSHSRTPAYYPNAGLIKNYCRNPDPVAAPWCYTTDPSVRWEYC NLTRCSDAEWTAFVPPNVILAPSLEAFFEQALTEETPGVQDCYYHYGQSYRGTYSTTVTGRTCQAWSSMTPHQHSRTPEN YPNAGLTRNYCRNPDAEIRPWCYTMDPSVRWEYCNLTQCLVTESSVLATLTVVPDPSTEASSEEAPTEQSPGVQDCYHGD GQSYRGSFSTTVTGRTCQSWSSMTPHWHQRTTEYYPNGGLTRNYCRNPDAEISPWCYTMDPNVRWEYCNLTQCPVTESSV LATSTAVSEQAPTEQSPTVQDCYHGDGQSYRGSFSTTVTGRTCQSWSSMTPHWHQRTTEYYPNGGLTRNYCRNPDAEIRP WCYTMDPSVRWEYCNLTQCPVMESTLLTTPTVVPVPSTELPSEEAPTENSTGVQDCYRGDGQSYRGTLSTTITGRTCQSW SSMTPHWHRRIPLYYPNAGLTRNYCRNPDAEIRPWCYTMDPSVRWEYCNLTRCPVTESSVLTTPTVAPVPSTEAPSEQAP PEKSPVVQDCYHGDGRSYRGISSTTVTGRTCQSWSSMIPHWHQRTPENYPNAGLTENYCRNPDSGKQPWCYTTDPCVRWE YCNLTQCSETESGVLETPTVVPVPSMEAHSEAAPTEQTPVVRQCYHGNGQSYRGTFSTTVTGRTCQSWSSMTPHRHQRTP ENYPNDGLTMNYCRNPDADTGPWCFTMDPSIRWEYCNLTRCSDTEGTVVAPPTVIQVPSLGPPSEQDCMFGNGKGYRGKK ATTVTGTPCQEWAAQEPHRHSTFIPGTNKWAGLEKNYCRNPDGDINGPWCYTMNPRKLFDYCDIPLCASSSFDCGKPQVE PKKCPGSIVGGCVAHPHSWPWQVSLRTRFGKHFCGGTLISPEWVLTAAHCLKKSSRPSSYKVILGAHQEVNLESHVQEIE VSRLFLEPTQADIALLKLSRPAVITDKVMPACLPSPDYMVTARTECYITGWGETQGTFGTGLLKEAQLLVIENEVCNHYK YICAEHLARGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYARVSRFVTWIEGMMRNN 4124 4201 1KIV 1 80 P08519 A 1 1 78 2 anti-parallel A TRP 62 A TRP 60 A PHE 64 A PHE 62 A TRP 72 A TRP 70 A TYR 74 A TYR 72 LYSINE BINDING SITE Unknown 6 A ARG 35 A ARG 35 6 1_555 A ASP 55 A ASP 54 6 1_555 A ASP 57 A ASP 56 6 1_555 A TRP 62 A TRP 60 6 1_555 A ARG 71 A ARG 69 6 1_555 A TRP 72 A TRP 70 6 1_555 19 P 21 21 21